Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joel Sheinfeld

Showing results (71-80 of 115) with videos related to

Pageof 12
Sort By:
Urology|December 29, 2011
Clinical impact of residual extraretroperitoneal masses in patients with advanced nonseminomatous germ cell testicular cancerTimothy A Masterson, Bobby Shayegan, Brett S Carver, et al.
The Journal of Urology|October 11, 2016
Clinical Outcome of Patients with Fibrosis/Necrosis at Post-Chemotherapy Retroperitoneal Lymph Node Dissection for Advanced Germ Cell TumorsRoy Mano, Maria F Becerra, Brett S Carver, et al.
Urology|October 9, 2018
Surgical Management of Patients with Advanced Germ Cell Tumors Following Salvage Chemotherapy: Memorial Sloan Kettering Cancer Center (MSKCC) ExperienceMariam Imnadze Miller, Andrew Feifer, Darren R Feldman, et al.
The Journal of Urology|August 25, 2014
Rates of teratoma and viable cancer at post-chemotherapy retroperitoneal lymph node dissection after induction chemotherapy for good risk nonseminomatous germ cell tumorsShilajit D Kundu, Darren R Feldman, Brett S Carver, et al.
Investigational New Drugs|January 24, 2004
Phase II trial of temozolomide in patients with cisplatin-refractory germ cell tumorsG Varuni Kondagunta, Jennifer Bacik, Lawrence Schwartz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2003
Chemotherapy for teratoma with malignant transformationAlessia C Donadio, Robert J Motzer, Dean F Bajorin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2002
Phase I trial of intravesical gemcitabine in bacillus Calmette-Guérin-refractory transitional-cell carcinoma of the bladderGuido Dalbagni, Paul Russo, Joel Sheinfeld, et al.
Urology|March 8, 2011
Outcomes after resection of postchemotherapy residual neck mass in patients with germ cell tumors--an updateAmit Gupta, Andrew H Feifer, Geoffrey T Gotto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2002
Salvage chemotherapy for patients with advanced pure seminomaJacqueline Vuky, Satish K Tickoo, Joel Sheinfeld, et al.
Cancer|July 28, 2011
Progression-free and overall survival in patients with relapsed/refractory germ cell tumors treated with single-agent chemotherapy: endpoints for clinical trial designDarren R Feldman, Sujata Patil, Michael J Trinos, et al.
Pageof 12

Showing results (71-80 of 115) with videos related to

Sort By:
Pageof 12
Urology|December 29, 2011
Clinical impact of residual extraretroperitoneal masses in patients with advanced nonseminomatous germ cell testicular cancerTimothy A Masterson, Bobby Shayegan, Brett S Carver, et al.
The Journal of Urology|October 11, 2016
Clinical Outcome of Patients with Fibrosis/Necrosis at Post-Chemotherapy Retroperitoneal Lymph Node Dissection for Advanced Germ Cell TumorsRoy Mano, Maria F Becerra, Brett S Carver, et al.
Urology|October 9, 2018
Surgical Management of Patients with Advanced Germ Cell Tumors Following Salvage Chemotherapy: Memorial Sloan Kettering Cancer Center (MSKCC) ExperienceMariam Imnadze Miller, Andrew Feifer, Darren R Feldman, et al.
The Journal of Urology|August 25, 2014
Rates of teratoma and viable cancer at post-chemotherapy retroperitoneal lymph node dissection after induction chemotherapy for good risk nonseminomatous germ cell tumorsShilajit D Kundu, Darren R Feldman, Brett S Carver, et al.
Investigational New Drugs|January 24, 2004
Phase II trial of temozolomide in patients with cisplatin-refractory germ cell tumorsG Varuni Kondagunta, Jennifer Bacik, Lawrence Schwartz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2003
Chemotherapy for teratoma with malignant transformationAlessia C Donadio, Robert J Motzer, Dean F Bajorin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2002
Phase I trial of intravesical gemcitabine in bacillus Calmette-Guérin-refractory transitional-cell carcinoma of the bladderGuido Dalbagni, Paul Russo, Joel Sheinfeld, et al.
Urology|March 8, 2011
Outcomes after resection of postchemotherapy residual neck mass in patients with germ cell tumors--an updateAmit Gupta, Andrew H Feifer, Geoffrey T Gotto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2002
Salvage chemotherapy for patients with advanced pure seminomaJacqueline Vuky, Satish K Tickoo, Joel Sheinfeld, et al.
Cancer|July 28, 2011
Progression-free and overall survival in patients with relapsed/refractory germ cell tumors treated with single-agent chemotherapy: endpoints for clinical trial designDarren R Feldman, Sujata Patil, Michael J Trinos, et al.
Pageof 12